Development of a high-performance liquid chromatographic-electrospray mass spectrometric assay for the specific and sensitive quantification of the novel immunosuppressive macrolide 40-O-(2-hydroxyethyl)rapamycin. 1998

I Segarra, and T R Brazelton, and N Guterman, and B Hausen, and W Jacobsen, and R E Morris, and L Z Benet, and U Christians
Department of Biopharmaceutical Sciences, University of California at San Francisco, 94143-0446, USA.

It was our objective to develop a rapid, sensitive and specific assay to quantify the immunosuppressive macrolide 40-O-(2-hydroxyethyl)rapamycin (SDZ-RAD) in blood of transplant patients. SDZ-RAD was extracted from blood by solid-liquid extraction. SDZ-RAD and its internal standard 28,40-diacetyl rapamycin were quantified using HPLC-electrospray MS. The assay was linear from 0.1 to 100 microg/l (r2 = 0.99). The mean recovery was 83% for SDZ-RAD and 80.5% for the internal standard. The mean day-to-day precision was 8.0%. Extracted samples were stable at 20 degrees C for at least 48 h and SDZ-RAD blood samples at -80 degrees C for at least six months.

UI MeSH Term Description Entries
D007166 Immunosuppressive Agents Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. Immunosuppressant,Immunosuppressive Agent,Immunosuppressants,Agent, Immunosuppressive,Agents, Immunosuppressive
D012015 Reference Standards A basis of value established for the measure of quantity, weight, extent or quality, e.g. weight standards, standard solutions, methods, techniques, and procedures used in diagnosis and therapy. Standard Preparations,Standards, Reference,Preparations, Standard,Standardization,Standards,Preparation, Standard,Reference Standard,Standard Preparation,Standard, Reference
D002851 Chromatography, High Pressure Liquid Liquid chromatographic techniques which feature high inlet pressures, high sensitivity, and high speed. Chromatography, High Performance Liquid,Chromatography, High Speed Liquid,Chromatography, Liquid, High Pressure,HPLC,High Performance Liquid Chromatography,High-Performance Liquid Chromatography,UPLC,Ultra Performance Liquid Chromatography,Chromatography, High-Performance Liquid,High-Performance Liquid Chromatographies,Liquid Chromatography, High-Performance
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000068338 Everolimus A derivative of sirolimus and an inhibitor of TOR SERINE-THREONINE KINASES. It is used to prevent GRAFT REJECTION in heart and kidney transplant patients by blocking cell proliferation signals. It is also an ANTINEOPLASTIC AGENT. Zortress,40-O-(2-hydroxyethyl)-rapamycin,Afinitor,Certican,RAD 001,RAD001,SDZ RAD,SDZ-RAD,001, RAD,RAD, SDZ
D012680 Sensitivity and Specificity Binary classification measures to assess test results. Sensitivity or recall rate is the proportion of true positives. Specificity is the probability of correctly determining the absence of a condition. (From Last, Dictionary of Epidemiology, 2d ed) Specificity,Sensitivity,Specificity and Sensitivity
D013058 Mass Spectrometry An analytical method used in determining the identity of a chemical based on its mass using mass analyzers/mass spectrometers. Mass Spectroscopy,Spectrometry, Mass,Spectroscopy, Mass,Spectrum Analysis, Mass,Analysis, Mass Spectrum,Mass Spectrum Analysis,Analyses, Mass Spectrum,Mass Spectrum Analyses,Spectrum Analyses, Mass
D015203 Reproducibility of Results The statistical reproducibility of measurements (often in a clinical context), including the testing of instrumentation or techniques to obtain reproducible results. The concept includes reproducibility of physiological measurements, which may be used to develop rules to assess probability or prognosis, or response to a stimulus; reproducibility of occurrence of a condition; and reproducibility of experimental results. Reliability and Validity,Reliability of Result,Reproducibility Of Result,Reproducibility of Finding,Validity of Result,Validity of Results,Face Validity,Reliability (Epidemiology),Reliability of Results,Reproducibility of Findings,Test-Retest Reliability,Validity (Epidemiology),Finding Reproducibilities,Finding Reproducibility,Of Result, Reproducibility,Of Results, Reproducibility,Reliabilities, Test-Retest,Reliability, Test-Retest,Result Reliabilities,Result Reliability,Result Validities,Result Validity,Result, Reproducibility Of,Results, Reproducibility Of,Test Retest Reliability,Validity and Reliability,Validity, Face
D020123 Sirolimus A macrolide compound obtained from Streptomyces hygroscopicus that acts by selectively blocking the transcriptional activation of cytokines thereby inhibiting cytokine production. It is bioactive only when bound to IMMUNOPHILINS. Sirolimus is a potent immunosuppressant and possesses both antifungal and antineoplastic properties. Rapamycin,AY 22-989,I-2190A,Rapamune,AY 22 989,AY 22989,I 2190A,I2190A

Related Publications

I Segarra, and T R Brazelton, and N Guterman, and B Hausen, and W Jacobsen, and R E Morris, and L Z Benet, and U Christians
June 1998, Clinical chemistry,
I Segarra, and T R Brazelton, and N Guterman, and B Hausen, and W Jacobsen, and R E Morris, and L Z Benet, and U Christians
March 1989, Biomedical & environmental mass spectrometry,
I Segarra, and T R Brazelton, and N Guterman, and B Hausen, and W Jacobsen, and R E Morris, and L Z Benet, and U Christians
November 1998, Journal of chromatography. B, Biomedical sciences and applications,
I Segarra, and T R Brazelton, and N Guterman, and B Hausen, and W Jacobsen, and R E Morris, and L Z Benet, and U Christians
May 2002, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences,
I Segarra, and T R Brazelton, and N Guterman, and B Hausen, and W Jacobsen, and R E Morris, and L Z Benet, and U Christians
March 1995, Journal of chromatography. B, Biomedical applications,
I Segarra, and T R Brazelton, and N Guterman, and B Hausen, and W Jacobsen, and R E Morris, and L Z Benet, and U Christians
June 1987, Journal of chromatography,
I Segarra, and T R Brazelton, and N Guterman, and B Hausen, and W Jacobsen, and R E Morris, and L Z Benet, and U Christians
July 2004, Journal of mass spectrometry : JMS,
I Segarra, and T R Brazelton, and N Guterman, and B Hausen, and W Jacobsen, and R E Morris, and L Z Benet, and U Christians
October 2006, Die Pharmazie,
I Segarra, and T R Brazelton, and N Guterman, and B Hausen, and W Jacobsen, and R E Morris, and L Z Benet, and U Christians
January 1996, Journal of chromatography. A,
I Segarra, and T R Brazelton, and N Guterman, and B Hausen, and W Jacobsen, and R E Morris, and L Z Benet, and U Christians
June 2011, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences,
Copied contents to your clipboard!